Callan JMB Supports Texas and New Mexico with Measles Outbreak Response through Redistribution of MMR II Vaccines
- Successfully coordinated interstate vaccine redistribution of 1,300+ doses
- Demonstrated 100% efficiency with zero waste in both vaccines and shipping materials
- Showcased effective cold chain technology capabilities in maintaining required temperatures
- None.
Callan JMB redistributed more than 1,300 vaccine doses using its specialized cold chain reusable shippers from Westside CDC in Chicago to Texas and New Mexico, ensuring no vaccines went to waste
All of the shippers used in the distribution of the vaccines were recovered and recertified for reuse, resulting in none going into landfills
SPRING BRANCH, Texas, June 05, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced it has supported Texas and New Mexico in the response to measles outbreak in each state by redistributing doses of the MMR II vaccine from Chicago to their respective states.
Working with Westside CDC in Chicago, Illinois, Callan JMB packed and shipped, on behalf of their client, more than 1,300 doses of MMR II vaccine from Chicago to both Texas and New Mexico in the fight to contain the spread of the measles outbreaks.
Callan JMB used its specialized cold chain reusable shippers, which are equipped with active temperature monitoring devices to keep the vaccine doses at the required temperatures throughout transit. All the shippers used in the operation were recovered and recertified, ensuring none of them ended up in landfills.
“This was as efficient a model as possible for vaccine redistribution, with nothing wasted in terms of both vaccine doses and shipping materials," said Callan JMB’ Chief Operating Officer, Scott Bullard. "Our specialized cold chain technology was essential in ensuring the vaccines arrived at their destinations safely while maintaining the required temperatures throughout transit. This operation exemplified how public health departments from different states can collaborate effectively to ensure critical medications reach people's arms during outbreak responses, and we are proud to have facilitated this event.”
About Callan JMB Inc.
Callan JMB Inc. is an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services to secure medical materials and protect patients and communities with compliant, safe, and effective medicines. Our combined expertise in supply chain logistics, thermodynamics, biologics, inventory management, regulatory compliance and emergency preparedness is unparalleled in the industry. We offer a gold standard in client experience with customizable interfaces, next-level reliability in shipping and environmental sustainability in our specialty packaging.
Forward-Looking Statement
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs, such as “will,” “should,” “would,” “may,” and “could,” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance, or achievements to be materially different from any anticipated results, performance, or achievements for many reasons. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company’s forward-looking statements, please see the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. Investors and security holders are urged to read these documents free of charge on the SEC's website at: http://www.sec.gov. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, and disclaims any intention or obligation to update or revise any such forward-looking statements to reflect events or circumstances that subsequently occur, or of which the Company hereafter becomes aware.
Investor Contacts:
Valter Pinto, Managing Director
KCSA Strategic Communications
CallanJMB@kcsa.com
212.896.1254
FAQ
How many vaccine doses did Callan JMB (CJMB) redistribute to Texas and New Mexico?
What technology did CJMB use to maintain vaccine temperature during transit?
How did Callan JMB ensure environmental sustainability in the vaccine redistribution?
Where did the MMR II vaccines originate from before CJMB's redistribution?
